Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ozcan, G."" wg kryterium: Autor


Tytuł:
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.
Autorzy:
Soleimani M; Division of Medical Oncology, British Columbia Cancer-Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.
Thi M; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Janfaza S; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Ozcan G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Mazurek S; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Cancer Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Ozgun G; Division of Medical Oncology, British Columbia Cancer-Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.
Maurice-Dror C; Division of Medical Oncology, British Columbia Cancer-Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.
Eigl B; Division of Medical Oncology, British Columbia Cancer-Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Chi K; Division of Medical Oncology, British Columbia Cancer-Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Kollmannsberger C; Division of Medical Oncology, British Columbia Cancer-Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Nappi L; Division of Medical Oncology, British Columbia Cancer-Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. .; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 13; Vol. 14 (1), pp. 8603. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Renal Cell*/genetics
Carcinoma, Renal Cell*/therapy
Circulating MicroRNA*
Kidney Neoplasms*/genetics
Kidney Neoplasms*/therapy
MicroRNAs*/genetics
Humans ; Immunotherapy ; Biomarkers ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
EE217 Cancer-Related Mortality in Turkiye: Years of Life Lost and Productivity Costs.
Autorzy:
Akyol Ersoy, B. (AUTHOR)
Karadurmuş, N. (AUTHOR)
Incegul, B. (AUTHOR)
Batum, M. (AUTHOR)
Ozcan, G. (AUTHOR)
Ceylan, Y. (AUTHOR)
Weston, G. (AUTHOR)
Hughes, R. (AUTHOR)
Poellinger, B. (AUTHOR)
Bencina, G. (AUTHOR)
Malhan, S. (AUTHOR)
Cicin, I. (AUTHOR)
Pokaż więcej
Źródło:
Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS93-S93. 1p.
Czasopismo naukowe
Tytuł:
The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer.
Autorzy:
Ucaryilmaz Metin C; Graduate School of Health Sciences, Koç University, 34450 Istanbul, Turkey.
Ozcan G; Department of Medical Pharmacology, School of Medicine, Koç University, 34450 Istanbul, Turkey.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 May 30; Vol. 14 (11). Date of Electronic Publication: 2022 May 30.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies